arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BeOne Medicines Ltd.

ONC

$348.52 ▲ +18.52 (+5.61%) at close

13 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Neutral

auto_awesome

Analytical Summary

BeOne Medicines Ltd. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $494.1B

Dividend Yield —

Revenue Growth 40.2% ↘

Op. Margin 8.4% ↗

ROIC 5.9% ↗

FCF / Share $0.66 ↗

Trailing P/E 1742.6x

Price / Book 115.2x

FCF Yield 0.2%

Debt / Equity 0.19

info Valuation on last close. End-of-day price, Aug 7, 2026.

13-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$5.34B

↑ +40.2% —

Net Income Profit after all expenses

$286.93M

↑ +144.5% —

Operating Margin Operating profit as % of sales

8.4%

↑ +156.1% 52th

FCF / Share Free cash flow per share

$0.66

↑ +243.6% —

Long-Term Debt Long-term obligations

$836.37M

↑ +402.4% —

Health Breakdown

Profitability

Returns

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue Growth YoY (%)	40.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+403%)	55.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+587%)	73.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+821%)	20.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+155%)	280.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3410%)	-27.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-448%)	116.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1350%)	-16.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-311%)	22179.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+277139%)	-87.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1198%)	-32.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-505%)	—	—
EPS Growth YoY (%)	N/M	27.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	56.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-23.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	17.7% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	26.9% Excellent ↑ Excellent Improving Year-over-year change in net income	56.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-37.5% Weak ↓ Weak Declining Year-over-year change in net income	8.7% Fair ↑ Fair Improving Year-over-year change in net income	-68.3% Weak ↑ Weak Improving Year-over-year change in net income	-40.8% Weak ↑ Weak Improving Year-over-year change in net income	-623.7% Weak ↓ Weak Declining Year-over-year change in net income	21.9% Good ↑ Good Improving Year-over-year change in net income	-108.8% Weak Weak Year-over-year change in net income	-212.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	63.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	6.8% Fair ↑ Fair Improving Year-over-year change in free cash flow	-5.0% Weak Weak Year-over-year change in free cash flow	-0.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	55.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	48.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	99.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	49.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	81.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	9.0% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	636.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	182.2% Excellent Excellent Compound annual revenue growth over 3 years	163.5% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	76.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	54.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	65.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	42.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	305.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	103.7% Excellent Excellent Compound annual revenue growth over 5 years	101.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Operating Margin (%) (%)	8.4% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-44%)	-14.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-199%)	-49.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-427%)	-126.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-943%)	-122.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-915%)	—	-224.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1594%)	-356.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2474%)	-41.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-375%)	—	—	-120.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-906%)	—
Effective Tax Rate (%) (%)	31.2% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	-21.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	5.4% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-55%)	-16.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-241%)	-35.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-399%)	-141.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1279%)	-123.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1133%)	—	-221.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1946%)	-339.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2933%)	-39.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-425%)	—	—	-140.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1269%)	—
FCF Margin (%) (%)	17.6% Good ↑ Good Improving Free cash flow as a percentage of revenue Optimal: > 10%	-16.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-69.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-128.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-132.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-453.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-196.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-311.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-14.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	3.28x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.95x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Return on Invested Capital (%)	5.9% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-72.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	55.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	29.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	5.5% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-9.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-59.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-48.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	6.6% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-56%)	-19.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-229%)	-24.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-266%)	-45.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-405%)	-23.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	-41.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-375%)	-98.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-757%)	-38.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-358%)	-13.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-33.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-325%)	56.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+274%)	34.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+130%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Debt to Equity (x)	0.19x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-68%)	0.05x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.06x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-91%)	0.05x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.05x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.09x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	0.02x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	—	—	—
Interest Coverage (x)	8.95x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	-12.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-58.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-82.48x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-49.17x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-90.54x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-63.34x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-319.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-78.14x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-141.72x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-4.49x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-3.70B	$-2.46B	$-2.97B	$-3.66B	$-4.17B	$-1.20B	$-534.70M	$-672.15M	$-230.38M	$-70.23M	$-17.87M	$-13.90M	$-3.93M
Debt / EBITDA (x)	1.44x Good ↑ Good Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.42x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.18x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.15x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.09x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.06x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.10x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.15x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue per Share (USD)	$3.77	$2.78	$1.81	$1.06	$0.98	$0.28	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.20	$-0.47	$-0.65	$-1.49	$-1.21	$-1.47	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$0.66	$-0.46	$-1.27	$-1.36	$-1.29	$-1.29	—	—	—	—	—	—	—
Book Value per Share (USD)	$3.03	$2.40	$2.60	$3.23	$4.59	$3.25	$1.20	$2.24	$1.13	$0.68	$-0.88	—	—
Tangible Book Value per Share (USD)	$3.03	$2.40	$2.60	$3.23	$4.59	$3.25	$1.20	$2.24	$1.13	$0.68	$-0.88	—	—
Basic Weighted Avg Shares (shares)	1.42B	1.37B	1.36B	1.34B	1.21B	1.09B	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Working Capital (USD)	$4.40B	$1.78B	$2.39B	$3.74B	$6.01B	$3.89B	$862.38M	$1.70B	$763.51M	$339.34M	$71.10M	—	—
LT Debt (USD)	$836.37M	$166.48M	$197.62M	$209.15M	$202.11M	$183.64M	$83.31M	$40.78M	$9.22M	$17.28M	—	—	—
Total Equity (USD)	$4.36B	$3.33B	$3.54B	$4.38B	$6.13B	$3.87B	$962.21M	$1.74B	$669.81M	$352.91M	$-101.77M	$-53.04M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Sales/Revenue/Turnover (USD)	$5.34B	$3.81B	$2.46B	$1.42B	$1.18B	$308.87M	$428.21M	$198.22M	$238.39M	$1.07M	$8.82M	$13.04M	—
Depreciation Expense (USD)	$141.69M	$171.76M	$87.67M	$66.28M	$46.46M	$31.79M	$18.62M	$10.39M	$4.76M	$1.91M	$1.54M	$1.56M	—
Net Income, GAAP (USD)	$286.93M	$-644.79M	$-881.71M	$-2.00B	$-1.46B	$-1.60B	$-948.63M	$-673.77M	$-93.11M	$-119.22M	$-57.10M	$-18.28M	—
Operating Cash Flow (USD)	$1.13B	$-140.63M	$-1.16B	$-1.50B	$-1.30B	$-1.28B	$-750.27M	$-547.72M	$12.75M	$-89.51M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 47 quarters

BeOne Medicines Ltd.

Analytical Summary

13-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare ONC with peers